Skip to main content
Equibles

NSRX · Nasus Pharma Ltd · Exempt Offerings

Track NSRX — free

Use NSRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NSRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.40 +0.05 (+1.64%) At close · Sep 11
Rebalance outlook locked
Market Cap
$39.88M
Shares
11.71M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2026-02-25 New $15,000,040 $15,000,040
Showing 1–1 of 1 filings
Key facts CIK 2029039 CUSIP M7071P109 13F (30d) 6 filings 6 filers Visit website Investor relations